Stocks and Investing Stocks and Investing
Tue, June 14, 2022
Mon, June 13, 2022

Andreas Argyrides Initiated (BMRN) at Hold and Held Target at $70 on, Jun 13th, 2022


Published on 2024-10-27 21:29:25 - WOPRAI, Andreas Argyrides
  Print publication without navigation


Andreas Argyrides of Wedbush, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $70 on, Jun 13th, 2022.

Andreas has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 0 agree with Andreas's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andreas


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $106 on, Monday, June 6th, 2022
  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $113 on, Monday, April 25th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $125 on, Thursday, February 24th, 2022

Contributing Sources